Last reviewed · How we verify
Vincristine, Irinotecan, Temozolomide
Vincristine, Irinotecan, Temozolomide is a Small molecule drug developed by Centre Oscar Lambret. It is currently in Phase 2 development. Also known as: Vincristine-Irinotecan-Temozolomide.
At a glance
| Generic name | Vincristine, Irinotecan, Temozolomide |
|---|---|
| Also known as | Vincristine-Irinotecan-Temozolomide |
| Sponsor | Centre Oscar Lambret |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma (PHASE3)
- Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) (PHASE1, PHASE2)
- Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes (PHASE1)
- Comprehensive Analysis of Chemotherapy and Targeted Therapy Outcomes in Recurrent Malignant Gliomas
- Liposomal Irinotecan, Vincristine, Temozolomide, and Anlotinib for R/R Pediatric Solid Tumors (PHASE2)
- Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors (PHASE1, PHASE2)
- Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors (PHASE2)
- Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vincristine, Irinotecan, Temozolomide CI brief — competitive landscape report
- Vincristine, Irinotecan, Temozolomide updates RSS · CI watch RSS
- Centre Oscar Lambret portfolio CI
Frequently asked questions about Vincristine, Irinotecan, Temozolomide
What is Vincristine, Irinotecan, Temozolomide?
Vincristine, Irinotecan, Temozolomide is a Small molecule drug developed by Centre Oscar Lambret.
Who makes Vincristine, Irinotecan, Temozolomide?
Vincristine, Irinotecan, Temozolomide is developed by Centre Oscar Lambret (see full Centre Oscar Lambret pipeline at /company/centre-oscar-lambret).
Is Vincristine, Irinotecan, Temozolomide also known as anything else?
Vincristine, Irinotecan, Temozolomide is also known as Vincristine-Irinotecan-Temozolomide.
What development phase is Vincristine, Irinotecan, Temozolomide in?
Vincristine, Irinotecan, Temozolomide is in Phase 2.
Related
- Manufacturer: Centre Oscar Lambret — full pipeline
- Also known as: Vincristine-Irinotecan-Temozolomide
- Compare: Vincristine, Irinotecan, Temozolomide vs similar drugs
- Pricing: Vincristine, Irinotecan, Temozolomide cost, discount & access